[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648031":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":12,"centralContacts":23,"locations":33,"responsibleParty":47,"collaborators":12,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":12,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":12,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":77,"whyStopped":12,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Riga Stradins University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control group","NO_INTERVENTION","The control group will maintain their routine activities and usual care and will receive the American College of Sports Medicine (ACSM) guidelines (Campbell et al., 2019), but they will not be assigned any structured physical exercise program during the study period.",null,{"label":14,"type":15,"description":12,"interventionNames":16},"Intervention group","EXPERIMENTAL",[17],"Other: Intervention Group",[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":12},"Intervention Group","The intervention group will receive remotely supervised sessions conducted by health professionals approximately three times per week for 24 weeks, ensuring no more than 48 hours elapse between two sessions. Individually customized aerobic high intensity interval and resistance training sessions will be carried out on alternating days using a smartwatch, heart rate monitor (polar H10 sensor), resistance bands with real-time monitoring sensors (bandcizer sensor), and the linked smartphone applications (Resistance Band Tracker and Polar Flow).",[14],[24,29],{"name":25,"role":26,"phone":27,"phoneExt":12,"email":28},"Aija Klavina, PhD","CONTACT","+371 29203488","aija.klavina@rsu.lv",{"name":30,"role":26,"phone":31,"phoneExt":12,"email":32},"Sintija Liepina, Msc","+371 27825885","sintija.liepina@rsu.edu.lv",[34],{"facility":5,"status":12,"city":35,"state":12,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Riga","LV1007","Latvia","LV",{"type":40,"coordinates":41},"Point",[42,43],24.10589,56.946,{"lat":43,"lon":42},[46],{"name":25,"role":26,"phone":27,"phoneExt":12,"email":28},{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Aija Klavina","Dr. Aija Klavina, principal investigator, lead researcher at the Laboratory of Sports and nutrition research (RSU) and professor at the Lithuanian Sport University, Department of Rehabilitation and Health promotion.","100648031","remotely-supervised-exercise-during-chemotherapy-in-women-with-breast-cancer-100648031",false,"NCT07716306","Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer","Effect of Remotely Supervised Combined Aerobic and Resistance Exercise Training on Physical Health and Quality of Life in Women With Breast Cancer During Chemotherapy","Inclusion Criteria:\n\n* previously untreated primary breast cancer;\n* stage IIA-B, IIIA-C at diagnosis;\n* diagnosis established by core needle biopsy;\n* age 30-65 years;\n* prescribed doxorubicin\u002Fcyclophosphamide-based NACT.\n\nExclusion Criteria:\n\n* cardiac pathologies (assessed by echocardiogram);\n* blood transfusion in the last six months;\n* another oncological disease;\n* previous chemotherapy, hormonal or X-ray treatment;\n* participation in another clinical trial.","FEMALE","30 Years","65 Years",{"count":62,"type":63},60,"ESTIMATED","INTERVENTIONAL",[66],"NA","The RE-CARE project is designed to evaluate the effects of a 24-week, remotely supervised, combined high-intensity interval aerobic and resistance exercise training on physical health and quality of life in patients with breast cancer (BC) undergoing neoadjuvant chemotherapy (NACT). The study will enroll women aged 30-65 years with previously untreated, primary breast cancer, clinical stage IIA-IIB or IIIA-IIIC, who are scheduled to receive doxorubicin\u002Fcyclophosphamide-based NACT. Participants will be randomly allocated to either an experimental intervention group or a control group. At baseline, comprehensive assessments will be conducted to evaluate cardiorespiratory fitness, physical endurance, muscle strength, cognitive function, and health-related quality of life. The primary objective is to determine the impact of the remotely supervised combined aerobic and resistance exercise on incidence and severity of NACT-related adverse effects in patients with BC.",[69],"Breast Cancer",[71,72,73,74,75,76],"Breast cancer","Quality of life","Physical health","Combined exercise","Aerobic exercise","Resistance training","NOT_YET_RECRUITING","2026-07-16",{"date":80,"type":81},"2026-07-21","ACTUAL",{"date":83,"type":63},"2027-01",{"date":85,"type":63},"2028-10",{"name":5,"class":6},1]